Quick10K

⚲

Citizens & Northern

Filings

10-Q	2021-03-31	Filed 2021-05-07
10-K	2020-12-31	Filed 2021-03-05
10-Q	2020-09-30	Filed 2020-11-06
10-Q	2020-06-30	Filed 2020-08-06
10-Q	2020-03-31	Filed 2020-05-07
10-K	2019-12-31	Filed 2020-02-20
10-Q	2019-09-30	Filed 2019-11-12
10-Q	2019-06-30	Filed 2019-08-06
10-Q	2019-03-31	Filed 2019-05-07
10-K	2018-12-31	Filed 2019-02-21
10-Q	2018-09-30	Filed 2018-11-01
10-Q	2018-06-30	Filed 2018-08-06
10-Q	2018-03-31	Filed 2018-05-03
10-K	2017-12-31	Filed 2018-02-15
10-Q	2017-09-30	Filed 2017-11-02
10-Q	2017-06-30	Filed 2017-08-03
10-Q	2017-03-31	Filed 2017-05-04
10-K	2016-12-31	Filed 2017-02-16
10-Q	2016-09-30	Filed 2016-11-03
10-Q	2016-06-30	Filed 2016-08-04
10-Q	2016-03-31	Filed 2016-05-05
10-K	2015-12-31	Filed 2016-02-18
10-Q	2015-09-30	Filed 2015-11-05
10-Q	2015-06-30	Filed 2015-08-07
10-Q	2015-03-31	Filed 2015-05-08
10-K	2014-12-31	Filed 2015-02-26
10-Q	2014-09-30	Filed 2014-11-07
10-Q	2014-06-30	Filed 2014-08-08
10-Q	2014-03-31	Filed 2014-05-09
10-K	2013-12-31	Filed 2014-02-20
10-Q	2013-09-30	Filed 2013-11-07
10-Q	2013-06-30	Filed 2013-08-08
10-Q	2013-03-31	Filed 2013-05-09
10-K	2012-12-31	Filed 2013-02-21
10-Q	2012-09-30	Filed 2012-11-07
10-Q	2012-06-30	Filed 2012-08-07
10-Q	2012-03-31	Filed 2012-05-08
10-K	2011-12-31	Filed 2012-02-24
10-Q	2011-09-30	Filed 2011-11-07
10-Q	2011-06-30	Filed 2011-08-08
10-Q	2011-03-31	Filed 2011-05-06
10-K	2010-12-31	Filed 2011-03-01
10-Q	2010-09-30	Filed 2010-11-08
10-Q	2010-06-30	Filed 2010-08-06
10-Q	2010-03-31	Filed 2010-05-07
10-K	2009-12-31	Filed 2010-03-01

Reports

8-K	2021-01-21	Earnings, Exhibits
8-K	2020-10-22
8-K	2020-07-16
8-K	2020-07-01
8-K	2020-05-07
8-K	2020-04-16
8-K	2020-04-16
8-K	2020-04-02
8-K	2020-02-20
8-K	2020-01-16
8-K	2019-12-18
8-K	2019-10-17
8-K	2019-08-07
8-K	2019-07-18
8-K	2019-07-18
8-K	2019-06-12
8-K	2019-04-18
8-K	2019-04-18
8-K	2019-04-18
8-K	2019-04-01
8-K	2019-03-01
8-K	2019-01-17
8-K	2018-12-20
8-K	2018-10-18
8-K	2018-09-27
8-K	2018-08-24
8-K	2018-08-08
8-K	2018-07-19
8-K	2018-06-11
8-K	2018-04-19
8-K	2018-04-19
8-K	2018-04-19
8-K	2018-01-18

Citizens & Northern Financials

CZNC Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin


Comps ($MM TTM)	Market Cap	Gross Margin	EV/EBITDA	Ret on Assets	Assets	Liabilities	Revenue	G Profit	Net Income	EBITDA	EV
024 Pharma (EEIG)
Bioquest Corp (BQST)
11 Good Energy (ELVN)
BriaCell Therapeutics Corp. (BCTXW)
1347 Capital Corp (TFSC)
DD3 Acquisition Corp. II (DDMXW)
8i Acquisition 2 Corp. (LAX)
Acumen Pharmaceuticals, Inc. (ABOS)
Aerovate Therapeutics, Inc. (AVTE)
Ameren Illinois Co (AILNP)
Frontier Investment Corp (FICV)
Gobi Acquisition Corp. (GOBI)
HEALTH REVENUE ASSURANCE HOLDINGS, INC. (HRAA)
Ocean Biomedical, Inc. (OCEA)
SERA PROGNOSTICS, INC. (SERA)
Xiaoju Kuaizhi Inc. (DIDI)
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
COMSovereign Holding Corp. (COMSW)
ALABAMA POWER CO (APRCP)


Balance Sheet ($MM)	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash	49	56	57	52	64	38	55	40	31	38	39	55	54	50	32	32	31	28	33	38	24	30	29	29	31	30	37	34	49	36	37	44	40	51
Accounts Receivable
Inventory
PP&E	22	19	19	19	19	19	47	18	18	18	47	17	17	16	47	16	16	16	48	15	15	15	50	16	16	15	47	15	15	15	47	15	16	16
Assets	1,310	1,312	1,324	1,317	1,328	1,310	1,287	1,240	1,228	1,233	1,238	1,235	1,256	1,257	1,242	1,252	1,256	1,233	1,223	1,217	1,231	1,245	1,242	1,234	1,243	1,260	1,277	1,258	1,284	1,285	1,291	1,290	1,610	1,643
Accounts Payable
Long-Term Debt	133	128	125	115	110	90	84	77	73	73	73	73	73	73	73	73	63	63	39	39	39	39	38	38	38	31	9	18	27	33	36	33
Liabilities	1,156	1,151	1,156	1,145	1,151	1,130	1,104	1,057	1,049	1,052	1,058	1,050	1,067	1,070	1,054	1,063	1,069	1,042	1,036	1,028	1,040	1,055	1,056	1,047	1,054	1,069	1,089	1,072	1,095	1,095	1,094	1,088	1,370	1,400
Stockholders' Equity									179	181	179	185	189	187	188	189	187	190	187	188	191	191	186	187	190	191	188	186	189	190	197	202	240	243


Income Statement ($MM)	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Revenue
Cost of Revenue
Gross Profit
R&D
SG&A
Tax		2	1	0	3	1	0	0	1	2	1	1	1	1	1	1	1	1	1	1	1	1	2	1	1	2	2	1	1	2	1	1	1	1
Net Income	6	6	6	6	6	5	6	5	5	5	4	4	4	4	4	4	4	4	4	4	4	4	4	3	4	4	2	4	7	6	6	5	4	5


Cash Flow ($MM)	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash Operating		5	10	3	6	8	10	7	11	8	4	6	7	3	6	4	6	5	4	4	5	5	5	4			4	6	6	6		3	5	9
Cash Investing		10	-13	6	1	-9	37	28	-9	0	-10	24	-22	-7	-5	-7	-9	22	12	15	-28	-9	-7	8			-13	11	-11	-16		13	62	-18
Cash Financing		-8	4	-14	6	-26	-30	-50	-11	-2	7	-14	14	-1	-19	3	2	-30	-11	-13	8	10	1	-12			16	-20	20	-3		-9	-72	21